Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Sperm quality biomarkers complement reproductive and endocrine parameters in investigating environmental contaminants in common carp (Cyprinus carpio) from the Lake Mead National Recreation Area.

Jenkins JA, Rosen MR, Draugelis-Dale RO, Echols KR, Torres L, Wieser CM, Kersten CA, Goodbred SL.

Environ Res. 2018 Feb 10;163:149-164. doi: 10.1016/j.envres.2018.01.041. [Epub ahead of print]

PMID:
29438900
2.

Raster-Scanning Optoacoustic Mesoscopy for Gastrointestinal Imaging at High Resolution.

Knieling F, Gonzales-Menezes J, Claussen J, Schwarz M, Neufert C, Fahlbusch FB, Rath T, Thoma OM, Kramer V, Menchicchi B, Kersten C, Scheibe K, Schürmann S, Carlé B, Rascher W, Neurath MF, Ntziachristos V, Waldner MJ.

Gastroenterology. 2018 Jan 5. pii: S0016-5085(18)30011-8. doi: 10.1053/j.gastro.2017.11.285. [Epub ahead of print] No abstract available.

PMID:
29309775
3.

Lifestyle changes in cancer patients undergoing curative or palliative chemotherapy: is it feasible?

Vassbakk-Brovold K, Berntsen S, Fegran L, Lian H, Mjåland O, Mjåland S, Nordin K, Seiler S, Kersten C.

Acta Oncol. 2017 Dec 14:1-8. doi: 10.1080/0284186X.2017.1413247. [Epub ahead of print]

PMID:
29239243
4.

Experiences of Patients With Breast Cancer of Participating in a Lifestyle Intervention Study While Receiving Adjuvant Chemotherapy.

Vassbakk-Brovold K, Antonsen AJ, Berntsen S, Kersten C, Fegran L.

Cancer Nurs. 2017 Feb 17. doi: 10.1097/NCC.0000000000000476. [Epub ahead of print]

PMID:
28221215
5.

The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.

Køstner AH, Kersten C, Löwenmark T, Ydsten KA, Peltonen R, Isoniemi H, Haglund C, Gunnarsson U, Isaksson B.

J Surg Oncol. 2016 Dec;114(7):895-899. doi: 10.1002/jso.24415. Epub 2016 Oct 3.

PMID:
27696432
6.

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer.

Thomsen M, Kersten C, Sorbye H, Skovlund E, Glimelius B, Pfeiffer P, Johansen JS, Kure EH, Ikdahl T, Tveit KM, Christoffersen T, Guren TK.

Oncotarget. 2016 Nov 15;7(46):75013-75022. doi: 10.18632/oncotarget.12601.

7.

Palliative pelvic radiotherapy for symptomatic rectal cancer - a prospective multicenter study.

Cameron MG, Kersten C, Vistad I, van Helvoirt R, Weyde K, Undseth C, Mjaaland I, Skovlund E, Fosså SD, Guren MG.

Acta Oncol. 2016 Dec;55(12):1400-1407. Epub 2016 Jun 22.

PMID:
27332723
8.

Spiritual Well-being in Patients With Metastatic Colorectal Cancer Receiving Noncurative Chemotherapy: A Qualitative Study.

Rohde G, Kersten C, Vistad I, Mesel T.

Cancer Nurs. 2017 May/Jun;40(3):209-216. doi: 10.1097/NCC.0000000000000385.

9.

Cancer patients participating in a lifestyle intervention during chemotherapy greatly over-report their physical activity level: a validation study.

Vassbakk-Brovold K, Kersten C, Fegran L, Mjåland O, Mjåland S, Seiler S, Berntsen S.

BMC Sports Sci Med Rehabil. 2016 Apr 19;8:10. doi: 10.1186/s13102-016-0035-z. eCollection 2016.

10.

Humbilical & Epigastric Hernia.

DeAsis F, Gitelis M, Chao S, Lapin B, Linn J, Denham W, Haggerty S, Carbray J, Ujiki M, Olory-Togbe JL, Gbessi DG, Dossou FM, Lawani I, Souaibou YI, Gnangnon I, Denakpo M, Soton RR, Djrouo G, Gogan P, Trukhalev W, Kukosh M, Panyushkin A, Safronova E, Jairam A, Kaufmann R, Jeekel J, Lange JF, Volmer U, Kersten CC, Arlt G, Skach J, Harcubova R, Petrakova V, Mandoboy JD, Ngom G, Faye AL, Ndour O, Sankale AA, Ndoye M, Daneiii P, Leone N, Ballerini A, Bondurri A, Cavallaro G, Silecchia G, Raparelli L, Greco F, Iorio O, Iossa A, De Angelis F, Rizzello M, Olmi S, Cesana G, Baldazzi G, Manoocheri F, Campanile FC, Munipalle P, Khan S, Gwiti P, Kanakala V, Viswanath Y, Kokotovic D, Sjølander H, Gögenur I, Helgstrand F, Devadhar S, Hounnou G, Elegbede OT, Hadonou AA, Mensah ED, Agossou-Voyeme AK, Konate I, Toure AO, Cisse M, Zaki M, Diao ML, Tendeng JN, Toure FB, Toure CT, Subramanian V, Froghi F, de Carvalho FC, Salimin L, Drabble E.

Hernia. 2015 Apr;19 Suppl 1:S35-42. doi: 10.1007/BF03355324. No abstract available.

PMID:
26518843
11.

Epidermal growth factor receptor-inhibition (EGFR-I) in the treatment of neuropathic pain.

Kersten C, Cameron MG, Laird B, Mjåland S.

Br J Anaesth. 2015 Nov;115(5):761-7. doi: 10.1093/bja/aev326.

12.

Individualized Comprehensive Lifestyle Intervention in Patients Undergoing Chemotherapy with Curative or Palliative Intent: Who Participates?

Vassbakk-Brovold K, Berntsen S, Fegran L, Lian H, Mjåland O, Mjåland S, Seiler S, Kersten C.

PLoS One. 2015 Jul 15;10(7):e0131355. doi: 10.1371/journal.pone.0131355. eCollection 2015.

13.

Palliative pelvic radiotherapy for symptomatic incurable prostate cancer – A prospective multicenter study.

Cameron MG, Kersten C, Vistad I, van Helvoirt R, Weyde K, Undseth C, Mjaaland I, Skovlund E, Fosså SD, Guren MG.

Radiother Oncol. 2015 Jun;115(3):314-20. doi: 10.1016/j.radonc.2015.05.021. Epub 2015 Jun 16.

14.

Maintenance Therapy With Cetuximab Every Second Week in the First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-7.5 Study by the Nordic Colorectal Cancer Biomodulation Group.

Pfeiffer P, Sorbye H, Qvortrup C, Karlberg M, Kersten C, Vistisen K, Lindh B, Bjerregaard JK, Glimelius B.

Clin Colorectal Cancer. 2015 Sep;14(3):170-6. doi: 10.1016/j.clcc.2015.03.002. Epub 2015 Mar 25.

PMID:
25956187
15.

Randomized trial of the effectiveness of a non-pharmacological multidisciplinary face-to-face treatment program on daily function compared to a telephone-based treatment program in patients with generalized osteoarthritis.

Cuperus N, Hoogeboom TJ, Kersten CC, den Broeder AA, Vlieland TP, van den Ende CH.

Osteoarthritis Cartilage. 2015 Aug;23(8):1267-75. doi: 10.1016/j.joca.2015.04.007. Epub 2015 Apr 14.

16.

Palliative Cancer Patients' Experiences of Participating in a Lifestyle Intervention Study While Receiving Chemotherapy.

Mikkelsen HE, Brovold KV, Berntsen S, Kersten C, Fegran L.

Cancer Nurs. 2015 Nov-Dec;38(6):E52-8. doi: 10.1097/NCC.0000000000000235.

PMID:
25730593
17.

Phosphatidylinositol 4,5-bisphosphate is an HCV NS5A ligand and mediates replication of the viral genome.

Cho NJ, Lee C, Pang PS, Pham EA, Fram B, Nguyen K, Xiong A, Sklan EH, Elazar M, Koytak ES, Kersten C, Kanazawa KK, Frank CW, Glenn JS.

Gastroenterology. 2015 Mar;148(3):616-25. doi: 10.1053/j.gastro.2014.11.043. Epub 2014 Dec 2.

18.

Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.

Naume B, Synnestvedt M, Falk RS, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Sommer HH, Sætersdal AB, Rypdal MC, Bendigtsen Schirmer C, Wist EA, Borgen E.

J Clin Oncol. 2014 Dec 1;32(34):3848-57. doi: 10.1200/JCO.2014.56.9327. Epub 2014 Nov 3.

PMID:
25366688
19.

The clinical burden of generalized osteoarthritis represented by self-reported health-related quality of life and activity limitations: a cross-sectional study.

Cuperus N, Vliet Vlieland TP, Mahler EA, Kersten CC, Hoogeboom TJ, van den Ende CH.

Rheumatol Int. 2015 May;35(5):871-7. doi: 10.1007/s00296-014-3149-1. Epub 2014 Oct 10.

PMID:
25300731
20.

FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab.

Kjersem JB, Skovlund E, Ikdahl T, Guren T, Kersten C, Dalsgaard AM, Yilmaz MK, Fokstuen T, Tveit KM, Kure EH.

BMC Cancer. 2014 May 19;14:340. doi: 10.1186/1471-2407-14-340.

Supplemental Content

Loading ...
Support Center